Literature DB >> 18852834

Levitating levetiracetam's status for status epilepticus.

Lawrence J Hirsch.   

Abstract

Entities:  

Year:  2008        PMID： 18852834      PMCID： PMC2566612          DOI： 10.1111/j.1535-7511.2008.00266.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  11 in total

1.  Antiepileptogenesis Therapy with Levetiracetam: Data from Kindling versus Status Epilepticus Models.

Authors:  F Edward Dudek; Edward H Bertram; Kevin J Staley
Journal:  Epilepsy Curr       Date:  2008 Jan-Feb       Impact factor: 7.500

2.  The status of intravenous valproate for status.

Authors:  Lawrence J Hirsch
Journal:  Epilepsy Curr       Date:  2007 Jul-Aug       Impact factor: 7.500

3.  Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.

Authors:  Steven Ramael; Agnès Daoust; Christian Otoul; Nathalie Toublanc; Mona Troenaru; Zhihong Sarah Lu; Armel Stockis
Journal:  Epilepsia       Date:  2006-07       Impact factor: 5.864

4.  A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group.

Authors:  D M Treiman; P D Meyers; N Y Walton; J F Collins; C Colling; A J Rowan; A Handforth; E Faught; V P Calabrese; B M Uthman; R E Ramsay; M B Mamdani
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

5.  Levetiracetam as a treatment option in non-convulsive status epilepticus.

Authors:  Sven Rupprecht; Kerstin Franke; Sabine Fitzek; Otto W Witte; Georg Hagemann
Journal:  Epilepsy Res       Date:  2006-12-08       Impact factor: 3.045

6.  Intravenous levetiracetam: treatment experience with the first 50 critically ill patients.

Authors:  Stephan Rüegg; Yvonne Naegelin; Martin Hardmeier; David T Winkler; Stephan Marsch; Peter Fuhr
Journal:  Epilepsy Behav       Date:  2008-03-04       Impact factor: 2.937

7.  Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus.

Authors:  S Knake; J Gruener; K Hattemer; K M Klein; S Bauer; W H Oertel; H M Hamer; F Rosenow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09-26       Impact factor: 10.154

8.  Determinants of success in the use of oral levetiracetam in status epilepticus.

Authors:  Andrea O Rossetti; Edward B Bromfield
Journal:  Epilepsy Behav       Date:  2006-02-21       Impact factor: 2.937

Review 9.  Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.

Authors:  Tim De Smedt; Robrecht Raedt; Kristl Vonck; Paul Boon
Journal:  CNS Drug Rev       Date:  2007

Review 10.  Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.

Authors:  Tim De Smedt; Robrecht Raedt; Kristl Vonck; Paul Boon
Journal:  CNS Drug Rev       Date:  2007
View more
  2 in total

1.  Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.

Authors:  Richard E Appleton; Naomi Ea Rainford; Carrol Gamble; Shrouk Messahel; Amy Humphreys; Helen Hickey; Kerry Woolfall; Louise Roper; Joanne Noblet; Elizabeth Lee; Sarah Potter; Paul Tate; Nadia Al Najjar; Anand Iyer; Vicki Evans; Mark D Lyttle
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

2.  Emergency treatment with levetiracetam or phenytoin in status epilepticus in children-the EcLiPSE study: study protocol for a randomised controlled trial.

Authors:  Mark D Lyttle; Carrol Gamble; Shrouk Messahel; Helen Hickey; Anand Iyer; Kerry Woolfall; Amy Humphreys; Naomi E A Bacon; Louise Roper; Franz E Babl; Stuart R Dalziel; Mary Ryan; Richard E Appleton
Journal:  Trials       Date:  2017-06-19       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.